SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950170-22-004297
Filing Date
2022-03-22
Accepted
2022-03-22 16:01:31
Documents
77
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 10-K scph-20211231.htm   iXBRL 10-K 2992290
2 EX-21.1 scph-ex21_1.htm EX-21.1 6793
3 EX-23.1 scph-ex23_1.htm EX-23.1 6109
4 EX-31.1 scph-ex31_1.htm EX-31.1 18399
5 EX-32.1 scph-ex32_1.htm EX-32.1 11662
  Complete submission text file 0000950170-22-004297.txt   10246306

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT scph-20211231_def.xml EX-101.DEF 187152
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT scph-20211231.xsd EX-101.SCH 55482
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT scph-20211231_cal.xml EX-101.CAL 62388
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT scph-20211231_lab.xml EX-101.LAB 501508
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT scph-20211231_pre.xml EX-101.PRE 371490
71 EXTRACTED XBRL INSTANCE DOCUMENT scph-20211231_htm.xml XML 1913985
Mailing Address 2400 DISTRICT AVENUE SUITE 310 BURLINGTON MA 01803
Business Address 2400 DISTRICT AVENUE SUITE 310 BURLINGTON MA 01803 617-517-0730
scPharmaceuticals Inc. (Filer) CIK: 0001604950 (see all company filings)

IRS No.: 465184075 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-38293 | Film No.: 22759452
SIC: 2834 Pharmaceutical Preparations